Clinical and biochemical characteristics of patients with somatic <i>HRAS</i> -mutant pheochromocytoma and paraganglioma
Patients with HRAS-mutant PPGL have higher plasma metanephrine levels and a higher risk of IHI and ICU transfer, which therefore requires personalized perioperative managements.
Authors
- Jingjing Jiang (ORCID: https://orcid.org/0000-0003-1886-2613)
- Jing Zhang (ORCID: https://orcid.org/0000-0003-1958-8169)
- Xiaowen Xu
- Nicole Bechmann (ORCID: https://orcid.org/0000-0002-6932-333X)
- Yingjie Shen (ORCID: https://orcid.org/0000-0001-7955-5313)
- Anze Yu (ORCID: https://orcid.org/0000-0002-3998-1198)
- Minghao Li (ORCID: https://orcid.org/0000-0002-8213-0612)
- Jing Wang (ORCID: https://orcid.org/0009-0009-5613-4191)
- Kai Cheng (ORCID: https://orcid.org/0000-0002-8919-1100)
- Zhi Li (ORCID: https://orcid.org/0000-0003-4062-5358)
- Longfei Liu (ORCID: https://orcid.org/0000-0003-0274-4057)
- Kun Wang (ORCID: https://orcid.org/0000-0001-9710-4575)
Institutions
- Central South University (CN)
- Sun Yat-sen University (CN)
- Fudan University (CN)
- National Clinical Research (US)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Xiangya Hospital Central South University (CN)
- University Hospital Carl Gustav Carus (DE)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1093/ejendo/lvaf250
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 0.00